HF
MDCX

HRT Financial’s Medicus Pharma MDCX Stock Holding History

HRT Financial’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,529
Closed -$42K – 4971
2025
Q4 		$42K Buy
+27,529
New +$59K ﹤0.01% 2900
2025
Q3 		– Sell
-11,099
Closed -$33K – 3878
2025
Q2 		$33K Buy
+11,099
New +$44.3K ﹤0.01% 2357

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HRT Financial's MDCX Position: Q1 2026 in Review

HRT Financial sold out of Medicus Pharma (MDCX) in Q1 2026, closing a stake of 27,529 shares — an estimated $42K sold.

HRT Financial first reported a position in MDCX in Q2 2025 and held it in 2 quarters. The position peaked at $42K in Q4 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q1 2026.

  • HRT Financial reported no remaining Medicus Pharma position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 27,529 Medicus Pharma shares in Q1 2026, an estimated $42K.
  • HRT Financial first reported a position in Medicus Pharma in Q2 2025 and held it in 2 quarters.
  • HRT Financial's Medicus Pharma position peaked at $42K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Medicus Pharma as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.